Tag

Mark Emberton is Professor of Interventional Oncology in the Division of Surgery and Interventional Science at University College London (UCL). He is also the Clinical Director of the Clinical Effectiveness Unit at the Royal College of Surgeons of England, a Consultant in Urological Oncology at the University College London Hospital, and a member of the Partners’ Council of the National Institute of Clinical Excellence (NICE).

Mark is a world-class expert in prostate cancer who lectures in premier medical institutions throughout the world, and has published more that 200 research papers in peer reviewed journals. He has interests in the design and development of clinical studies, and innovative projects aimed at improving the diagnostic and therapeutic pathways for men with prostate cancer, principally through the use of novel imaging techniques and minimally invasive therapies. Mark leads a research team of clinical innovators that combine knowhow and experience in bioengineering and nanotechnology, and regularly carries out clinical studies aimed at enhancing cancer therapies.